|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
||||||||||||
| 化学式 | C11H4N4O2 |
||||||||||||||
| 分子量 | 224.18 | CAS No. | 67200-34-4 | ||||||||||||
| Solubility (25°C)* | 体外 | DMSO (warmed with 50ºC water bath) | 15 mg/mL (66.91 mM) | ||||||||||||
| Water | Insoluble | ||||||||||||||
| Ethanol | Insoluble | ||||||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||||||
| 製品説明 | SMER3, the small-molecule enhancer of rapamycin (SMER), is an inhibitor of the Skp1-Cullin-F-box (SCF)Met30 ubiquitin ligase with IC50 of 51 nM. |
|---|---|
| in vitro | SMER3 specifically inhibits ubiquitination by recombinant reconstituted SCFMet30, selectively disassembles or prevents assembly of SCFMet30 but not other SCF complexes, and directly binds to Met30 (or Met30-Skp1 complex), but not Skp1 alone, which inhibits Met30 bounding to Skp1. This compound treatment is able to upregulate a set of methionine biosynthesis genes. It enhances rapamycin’s growth inhibitory effect by inhibition of SCFMet30 and blocking Met4 ubiquitination. [1] |
| キナーゼアッセイ | SCF E3 ligase assay | |
|---|---|---|
| GstSkp1, Cdc53, 6xHisMet30 and Rbx1 are co-expressed in Hi5 cells and SCFMet30 is purified on glutathione sepharose. Recombinant FLAG-6xHisMet4 is bound to SCFMet30 and the ligase/substrate complex is eluted with glutathione. Sic1 in vitro ubiquitination by recombinant SCFCdc4 is performed. To directly compare the effect of SMER3 on SCFMet30 and SCFCdc4, Met4 and Sic1 ubiquitination are assayed in a single reaction. Approximately 150 nM SCFMet30 and SCFCdc4 are incubated with DMSO (solvent control) or this compound for 20 min at 25 ℃. The reaction is started by addition of a final concentration of 250 nM yeast E1, 0.8 μM recombinant Cdc34 purified from E. coli36, 5 mM ATP, and 80 μM ubiquitin. Reactions are incubated at 30 ℃ and samples are taken after 5 min and 25 min reaction time to accommodate different reaction kinetics by the two SCFs. Products are separated on SDS-PAGE and analyzed by immunoblotting using anti-Met4 and anti-Sic1 antibodies. | ||
|
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。